Polar Capital Holdings Plc - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Polar Capital Holdings Plc ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$508,906
+22.6%
12,5470.0%0.00%
+33.3%
Q3 2022$415,000
-31.4%
12,547
-27.0%
0.00%
-25.0%
Q2 2022$605,000
-23.4%
17,1820.0%0.00%0.0%
Q1 2022$790,000
-30.6%
17,1820.0%0.00%0.0%
Q4 2021$1,139,000
+26.7%
17,182
+19.3%
0.00%0.0%
Q3 2021$899,000
+9.1%
14,407
+44.9%
0.00%0.0%
Q2 2021$824,000
-43.6%
9,945
-54.8%
0.00%
-55.6%
Q1 2021$1,460,00022,0180.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders